Antibacterial Hand Wash Recalled for Incorrect Scent Label
Woodbine Products is recalling FOAMFRESH DYE FREE ANTIBACTERIAL HAND WASH due to incorrect scent information on the label. The affected lots VDAF017 and VDAF018 were distributed in North Carolina, and no illnesses have been reported.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall involving only a labeling error. Per the severity rubric, cosmetic defects and documentation issues constitute Low severity, particularly when no safety hazard or illnesses are reported.
Plain-English summary
Woodbine Products Co Inc is recalling FOAMFRESH DYE FREE ANTIBACTERIAL HAND WASH (Chloroxylenol), a 1250 mL foaming hand wash, because the label lists incorrect information about the product's scent. The label does not accurately identify the actual scent of the product.
The recalled products are identified by Lot #VDAF017 (expiration 4/24) and Lot #VDAF018 (expiration 5/24). A total of 595 cases (4 bottles per case) were distributed in North Carolina.
No illnesses or injuries have been reported in connection with this product. Consumers who purchased the affected lots should verify the lot number on their bottle. For additional information, contact Woodbine Products Co Inc at 800-323-2251.
The recalled product
- Product
- FOAMFRESH DYE FREE ANTIBACTERIAL HAND WASH (CHLOROXYLENOL)
- Brand
- FOAMFRESH DYE FREE ANTIBACTERIAL HAND WASH
- Manufacturer
- Woodbine Products Co Inc
- Category
- Drug — Topical
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: VDAF017
- Exp 4/24
- VDAF018
- Exp 5/24
Distribution
Distributed in 1 state:
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27